These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38819303)

  • 1. Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context.
    Ruiz García Y; Marrazzo J; Martinón-Torres F; Workowski K; Giordano G; Pizza M; Sohn WY
    J Infect Dis; 2024 Oct; 230(4):e758-e767. PubMed ID: 38819303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
    Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
    PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
    Semchenko EA; Tan A; Borrow R; Seib KL
    Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of
    Petousis-Harris H; Radcliff FJ
    Front Immunol; 2019; 10():683. PubMed ID: 31024540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
    Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
    Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising developments in gonococcal vaccines.
    Waltmann A; Chen JS; Duncan JA
    Curr Opin Infect Dis; 2024 Feb; 37(1):63-69. PubMed ID: 38050729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress Toward a Gonococcal Vaccine: The Way Forward.
    Russell MW; Jerse AE; Gray-Owen SD
    Front Immunol; 2019; 10():2417. PubMed ID: 31681305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.
    Liu Y; Hammer LA; Daamen J; Stork M; Egilmez NK; Russell MW
    mSphere; 2023 Feb; 8(1):e0038822. PubMed ID: 36537786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
    Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
    mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Tzeng YL; Sannigrahi S; Borrow R; Stephens DS
    Front Immunol; 2024; 15():1350344. PubMed ID: 38440731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California.
    Bruxvoort KJ; Lewnard JA; Chen LH; Tseng HF; Chang J; Veltman J; Marrazzo J; Qian L
    Clin Infect Dis; 2023 Feb; 76(3):e1341-e1349. PubMed ID: 35642527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.
    Stejskal L; Thistlethwaite A; Ramirez-Bencomo F; Rashmi S; Harrison O; Feavers IM; Maiden MCJ; Jerse A; Barnes G; Chirro O; Chemweno J; Nduati E; Cehovin A; Tang C; Sanders EJ; Derrick JP
    Nat Commun; 2024 Aug; 15(1):6712. PubMed ID: 39112489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies.
    Beernink PT; Ispasanie E; Lewis LA; Ram S; Moe GR; Granoff DM
    J Infect Dis; 2019 Mar; 219(7):1130-1137. PubMed ID: 30346576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
    Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
    Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
    mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
    Edwards JL; Jennings MP; Apicella MA; Seib KL
    Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neisseria proteomics for antigen discovery and vaccine development.
    Christodoulides M
    Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.